SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

PhaseBio Announces Acquisition Of Novel Oral Aldosterone Synthase Inhibitor To Develop For Treatment-Resistant Hypertension; Terms Not Disclosed

Benzinga · -